ACS BrightEdge Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 5

Professionals

  • Investments
  • 84

  • Portfolio
  • 44

  • Exits
  • 18

Exits

ACS BrightEdge General Information

Company Description

Founded in 2018, BrightEdge is a corporate venture capital investment arm of the American Cancer Society based in Kennesaw, Georgia. The firm seeks to invest in early-stage companies operating in the cancer-focused therapeutics, education, food security, diagnostics, devices, and technologies sectors.

Business Details

Website
www.acsbrightedge.org
Year Founded
2018
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Impact Investing
Corporate Office
  • 3380 Chastain Meadows Parkway NorthWest
  • Suite 200
  • Kennesaw, GA 30144
  • United States
+1 (800)

ACS BrightEdge Investments (84)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Citrus Oncology 15-Sep-2026 Seed Round Clinics/Outpatient Services Generating Revenue
Cloverleaf Bio 08-Sep-2026 Drug Discovery Pre-Clinical Trials
Aakha Biologics 05-Aug-2026 Drug Discovery Generating Revenue
Alpheus Medical 30-Jul-2026 Surgical Devices Generating Revenue
Nemea Therapeutics 17-Jun-2026 Other Commercial Products Stealth
MedHaul 21-May-2026 Other Healthcare Technology Systems Generating Revenue
CellCentric 06-May-2026 Drug Discovery Clinical Trials - Phase 1
Neo Splice Therapeutics 28-Apr-2026 Biotechnology Startup
Pons 28-Apr-2026 Later Stage VC Diagnostic Equipment Generating Revenue
Cura Therapeutics 16-Apr-2026 Later Stage VC Biotechnology Pre-Clinical Trials
You’re viewing 10 of 84 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ACS BrightEdge Exits (18)

Company Name Exit Date Exit Type Exit Size
TailorMed Medical 02-Nov-2026 Buyout/LBO
Aumenta Biosciences 02-Aug-2026
Freenome 20-Jul-2026
Naveris 01-Jul-2026
Immunitas Therapeutics 12-May-2026
Maia Oncology 22-Apr-2026
Interius BioTherapeutics 14-Oct-2025
Modifi Bio 15-Oct-2024
Navigating Cancer 03-Sep-2024 Buyout/LBO
Vincere Health 27-Nov-2023 Merger/Acquisition
You’re viewing 10 of 18 exits. Get the full list »

ACS BrightEdge Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

ACS BrightEdge FAQs

  • What is ACS BrightEdge?

    Founded in 2018, BrightEdge is a corporate venture capital investment arm of the American Cancer Society based in Kennesaw, Georgia.

  • When was ACS BrightEdge founded?

    ACS BrightEdge was founded in 2018.

  • Where is ACS BrightEdge headquartered?

    ACS BrightEdge is headquartered in Kennesaw, GA.

  • What is ACS BrightEdge's total asset value?

    ACS BrightEdge has around in total assets under management.

  • How many investments has ACS BrightEdge made?

    ACS BrightEdge has made 84 investments.

  • What has ACS BrightEdge invested in?

    ACS BrightEdge has made numerous investments in companies like Citrus Oncology, Cloverleaf Bio, and Aakha Biologics within the Clinics/Outpatient Services and Drug Discovery industries.

  • What has ACS BrightEdge invested in recently?

    ACS BrightEdge's latest investment was on 15-Sep-2026 in Citrus Oncology, a company within the Clinics/Outpatient Services industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process